Ineos has launched a new clean hydrogen business to develop capacity for clean hydrogen across Europe.
Ineos already produces 300,000 t/y of hydrogen as a byproduct from chemical manufacturing operations and is involved in projects that aim to use hydrogen to replace high-carbon energy, feedstocks, and fuel. Ineos also has experience in large-scale electrolysis through its subsidiary Inovyn.
The new hydrogen business will be headquartered in the UK. Its aim is to build hydrogen capacity across Ineos sites in Europe, along with partner sites where hydrogen can be used to decarbonise energy. Ineos expects to develop new partnerships and will work closely with European governments to develop the hydrogen infrastructure needed for the green economy.
Wouter Bleukx, Business Unit Manager Hydrogen at Inovyn said “Hydrogen is an important part of a climate-neutral economy that has been discussed for decades. Finally, a hydrogen-fuelled economy is within reach as transportation in the UK, Germany, France and other countries begins to run on this carbon-free technology. With extensive experience in electrolysis, INEOS is uniquely placed to support these new opportunities, driven by emerging demand for affordable zero-carbon energy sources.”
by Amanda Doyle
This equipment will significantly lower the site’s CO2 emissions, reduce flaring and save around 60 gigawatt hours (GWh) energy each year. Project kick-off is in February 2021, with completion planned for 2023.
The acquisition significantly strengthens and expands Grace’s existing pharma portfolio. Pharma & Consumer is the largest, fastest growing and most profitable subsegment within Grace’s Materials Technologies business.
Solvay says it has decided to organize its soda ash and derivatives business into a separate and fully controlled legal structure.